henhaobio
Sign in

Computational and Structural Biotechnology JournalBioinformaticsPeer-reviewed journal article

D155Y Substitution of SARS-CoV-2 ORF3a Weakens Binding with Caveolin-1

Suchetana Gupta, Ditipriya Mallick, Kumarjeet Banerjee, Shrimon MukherjeeiD, Soumyadev SarkariD, Sonny T. M. LeeiD, Partha BasuchowdhuriiD, Siddhartha S. JanaiD

PDFDOIPreprint
Citations
13
FWCI
1.10
Field percentile
top 23%

Abstract

The clinical manifestation of the recent pandemic COVID-19, caused by the novel SARS-CoV-2 virus, varies from mild to severe respiratory illness. Although environmental, demographic and co-morbidity factors have an impact on the severity of the disease, contribution of the mutations in each of the viral genes towards the degree of severity needs a deeper understanding for designing a better therapeutic approach against COVID-19. Open Reading Frame-3a (ORF3a) protein has been found to be mutated at several positions. In this work, we have studied the effect of one of the most frequently occurring mutants, D155Y of ORF3a protein, found in Indian COVID-19 patients. Using computational simulations we demonstrated that the substitution at 155th changed the amino acids involved in salt bridge formation, hydrogen-bond occupancy, interactome clusters, and the stability of the protein compared with the other substitutions found in Indian patients. Protein-protein docking using HADDOCK analysis revealed that substitution D155Y weakened the binding affinity of ORF3a with caveolin-1 compared with the other substitutions, suggesting its importance in the overall stability of ORF3a-caveolin-1 complex, which may modulate the virulence property of SARS-CoV-2.

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISWu '20Hassan '21Sobitan '21Hassan '20Luan '21Hossain '21
72% semantic matchMicrobiology
S. Wu, C. Tian, P. Liu+5 more·bioRxiv·Aug 15, 2020